logo
logo
MEDP stock ticker logo

Medpace Holdings, Inc.

NASDAQ•MEDP
CEO: Dr. August James Troendle M.D.
セクター: Healthcare
業種: Medical - Diagnostics & Research
上場日: 2016-08-11
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
連絡先情報
5375 Medpace Way, Cincinnati, OH, 45227, United States
513-579-9911
www.medpace.com
時価総額
$13.35B
PER (TTM)
28.9
27.6
配当利回り
--
52週高値
$628.92
52週安値
$294.07
52週レンジ
52%
順位20Top 6.4%
6.1
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
強い • 6.1 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

深度リサーチ

財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書
直近12ヶ月
データなし